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relieve the cost of exposed hydrophobic domains
in the cytosol during ERAD.

ABSTRACT
Endoplasmic reticulum-associated degradation
(ERAD) plays a critical role for destruction of
terminally misfolded proteins at the secretory
pathway. The system also regulates expression
levels of several proteins such as Pca1p, a
cadmium exporter in yeast. To gain better insight
into the mechanisms underlying ERAD of Pca1p
and other polytopic proteins by the proteasome in
the cytosol, our study determined the roles for the
molecular factors of ERAD in dislodging Pca1p
from the ER. Inactivation of the 20S proteasome
leads to accumulation of ubiquitinylated Pca1p in
the ER membrane, suggesting a role for the
proteasome in extraction of Pca1p from the ER.
Pca1p formed a complex with the proteasome at
the membrane in a Doa10p E3 ligase dependent
manner. Cdc48p is required for recruiting the
proteasome to Pca1p. While Ufd2p E4 ubiquitin
chain extension enzyme is involved in efficient
degradation of Pca1p, Ufd2p-deficient cells did not
affect formation of a complex between Pca1p and
the proteasome. Two other polytopic membrane
proteins undergoing ERAD, Ste6*p and Hmg2p,
also displayed the same outcomes observed for
Pca1p. However, poly-ubiquitinylated Cpy1*p, a
luminal ERAD substrate, was detected in the
cytosol independent of proteolytic activities of the
proteasome. These results indicate that extraction
and degradation of polytopic membrane proteins at
the ER is a coupled event. This mechanism would

Buildup of misfolded proteins in the
endoplasmic reticulum (ER) induces the unfoldedprotein response (UPR) to enhance folding
capacity and reduce new protein synthesis (1-‐4).
Terminally misfolded proteins at the secretory
pathway are targeted to the ubiquitin-proteasome
dependent removal system, which is known as ERassociated degradation (ERAD) (3, 5-9).
Accumulation of misfolded proteins or excess
turnover is attributed to multiple diseases, such as
cystic fibrosis, diabetes, and amyotrophic lateral
sclerosis, as well as Alzheimer’s and Parkinson’s
diseases (3, 6, 7).
Several molecular factors involved in ERAD
have been characterized (10-13). In the yeast
Saccharomyces cerevisiae, misfolded ER luminal
proteins and proteins carrying misfolding(s) at the
transmembrane region(s) are ubiquitinylated by the
E3 ubiquitin ligase Hrd1p, whereas, proteins
carrying misfolding(s) at the cytosolic region(s) are
ubiquitinylated by Doa10p. While these E3
enzymes display substrate specificity, some
overlap also has been observed (14-17). In
congress with the E3 ubiquitin ligases, several
other components, such as E2 ubiquitin
conjugating enzymes, E4 ubiquitin extension
enzymes, and molecular chaperones work for
recognition and direction of substrates to ubiquitin
ligases and the proteasome (3, 13, 16). As the
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proteasome is in the cytosol, ERAD substrates from the ER for ERAD. Subcellular location,
must be mobilized from the ER lumen or dislodged physical interaction with the proteasome, and
from the membrane to be destroyed (18). The turnover rates of Pca1p were determined in yeast
Cdc48p AAA-ATPase (p97 in mammals) is cells using genetic and biochemical approaches.
thought to provide a primary driving force in the Our data indicates that extraction and degradation
process (10, 14, 19). It has been proposed that of Pca1p and two other polytopic membrane
translocation of luminal ERAD substrates to the proteins, Ste6*p and Hmg2p, are coordinated by
cytosol may occur through a translocon complex formation with the proteasome while they
(translocation channel) formed with several reside at the ER membrane. The mechanism is
proteins, such as Sec61p (20-28), and E3 ubiquitin likely significant for avoiding the release of
ligases possessing multi-transmembrane domains membrane proteins to the cytosol.
(e.g., Hrd1p) (29-31). E4 ubiquitin chain extension
enzymes (e.g., Ufd2p, Hul5p) facilitate ERAD Experimental Procedures
through poly-ubiquitinylation (10, 32, 33).
Despite
significant
progress
in
the
Yeast Strains and Growth Conditions - A
identification and characterization of molecular BY4741 haploid S. cerevisiae strain (MATa
factors involved in ERAD, the mechanisms of how his3_1, leu2_0, met15_0, ura3_0) and null mutants
proteins in the ER are targeted to the cytoplasmic of particular gene(s) including hul5::KanMX6
proteasome remained to be elucidated (3, 10, 32). (hul5Δ), ufd2::KanMX6 (ufd2Δ), rpn5::KanMX6
Integral membrane proteins might be dislodged (rpn5Δ), and doa10::KanMX6 (doa10Δ) were
from the membrane and escorted to the proteasome obtained from OpenBiosystems. A pdr5::KanMX6
for destruction (10), which requires the cells to (pdr5Δ) strain background was used for
extract proteins containing hydrophobic regions experiments in which cells were co-cultured with
and maintain their solubility in the cytosol. Thus, cycloheximide, MG132, or bortezomib. Strains of
direct loading of full-length substrates or doa10::His3 or ufd2::His3 in pdr5Δ background
fragmented pieces into the proteasome during the were generated by homologous recombination of a
extraction from the membrane could be a deletion cassette as previously described (36).
mechanism resolving the problem (32).
Yeast cells were cultured in synthetic
Our previous study showed that expression of complete (SC) medium [2 % (v/v) dextrose, 0.2 %
Pca1p cadmium efflux transporter in the yeast S. (v/v) amino acid mixture, and 0.67 % (v/v) yeast
cerevisiae is dependent upon the ERAD pathway nitrogen base] lacking specific amino acid(s) if
(34). In the absence of cadmium Pca1p is rapidly plasmid selection is necessary. Cells were cultured
turned over through a Doa10p and proteasome- at 30 oC unless specified.
dependent mechanism; however, when cadmium is
To inactivate Cdc48p and Cim3p, strains
present, Pca1p escapes from ERAD and is secreted expressing a temperature-sensitive CDC48 (cdc48to the plasma membrane to export cadmium (34, 3) or CIM3 (cim3-1) allele were cultured at
35). A degron at the N-terminal cytosolic domain permissive temperature (23 oC) and then shifted to
is responsible for the ERAD of Pca1p and also restrictive temperature (37 oC) for 30 min (37, 38).
senses cadmium to rescue Pca1p from ERAD.
To inhibit translation, cells at the mid-log
Because of its rapid turnover (T1/2 = <5 min) (34), a phase were co-cultured with cycloheximide (CHX)
degron rather than misfolding-dependent ERAD, (Sigma, 100 µg/mL) for a period as indicated in
and control of this process by cadmium, Pca1p is a each experiment. To inhibit the proteasome, cells
unique example among ERAD substrates. were co-cultured with MG132 (Cayman Chemical,
Moreover, the well-established experimental 20 µM) (39) or bortezomib (Selleck Chemicals, 20
systems in yeast and conserved mechanisms for µM) (40) for 2 hrs.
ERAD between yeast and mammals allow Pca1p
Plasmid Construction - A single copy yeast
to be a useful model substrate for gaining a better vector
p416-GPD
(41)
was
used
for
understanding of the mechanisms underlying glyceradehyde-3-phosphate dehydrogenase gene
ERAD of polytopic membrane proteins.
promoter-mediated constitutive expression of
Here we characterized the roles for the PCA1, N-terminal truncated PCA1 (35), CPY1*,
molecular factors involved in dislodging Pca1p STE6* and HMG2. Plasmids for hemagglutinin
2
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(HA) epitope tagging and green fluorescent protein
Flotation sucrose gradient fractionation was
(GFP) fusion at the N-terminus of Pca1p were performed as previously described (45). Yeast cells
conducted as previously described (35).
C- were broken using glass beads in the lysis buffer
terminal c-myc epitope tagging of Pca1p was (50 mM HEPES, 150 mM NaCl, 5 mM EDTA, 1
achieved by PCR cloning using a primer mM dithiothreitol (DTT), 1 mM PMSF, 50 mM
containing c-myc sequence prior to the stop codon. protease inhibitor cocktail). Sucrose gradient [0.25
Cpy1*p possesses the G255R substitution to be M, 1.5 M, ~1.7 M (mixture of 200 µl cell lysate
targeted to ERAD (13). Site-directed mutagenesis and 600 µl 2.3 M sucrose), and 2.3 M in
was accomplished by a primer overlap extension descending order] was spun at 4 oC at 100,000 x g
method (42). Two c-myc epitopes were inserted in for 5 hrs. Twelve fractions (300 µL each) were
the C-terminus of CPY1* for Western blotting then taken from the top.
analysis using anti-myc antibodies. HMG2
In vitro De-ubiquitinylation - The flotation
containing one c-myc epitope (43) was subcloned sucrose gradient fractions (10-12) were subjected
in p416-GPD vector. Common molecular biology to buffer exchange using Slide-A-Lyzer dialysis
techniques, including plasmid amplification using cassette (Thermo Scientific) in 500 mL of deEscherichia coli and purification, followed ubiquitinylation buffer (50 mM HEPES, 150 mM
previously established methods (77). Plasmid NaCl, 5 mM EDTA, 1 mM DTT, 1 mM PMSF,
transformation into yeast was performed using the protease inhibitor cocktail without sucrose),
lithium acetate method (44).
followed by incubation with 5 ng of USP2 catalytic
Fluorescence Microscopy - Cells cultured in domain (BML-UW9850-0100 Enzo-life sciences)
SC media were mixed with phosphate-buffered rocking at 37 oC for 1 hr. Samples were then
saline (PBS) containing NaN3 (15 mM) and NaF subjected to a second round of buffer exchange in
(15 mM) to inactivate cells. Cells were collected the same buffer without DTT.
Immunoby centrifugation and subjected to confocal precipitation was conducted using a kit
microscopy (Olympus FV500) as described (35).
(ProfoundTM c-Myc Tag IP/Co-IP application set,
Fractionation of Cell Lysates - Yeast cells Thermo Scientific) according to the manufacturer’s
were broken by vortexing (1 min, 5 times) with specifications.
glass beads in the PBS lysis buffer containing 1
In Vivo Cross-linking and ImmunomM phenylmethanesulfonyl fluoride (PMSF), 5 precipitation - Cells expressing Pca1p tagged with
mM ethylenediaminetetraacetic acid (EDTA), and HA epitope were co-cultured with a 20S
50 mM protease inhibitor cocktail (HaltTM, Thermo proteasome inhibitor MG132 (20 µM, 2 hrs). Cells
Scientific). Centrifugation (4 oC, 1,000 x g, 10 were collected by washing twice in ice-cold PBS
min) removed large cell debris and unbroken cells. and re-suspended in PBS containing MG132 and a
Soluble and membrane-associated proteins were membrane permeable thiol-reversible cross-linker,
separated by centrifugation (4 oC, 100,000 x g, 1 dimethyl 3,3’-dithiobispropionimidate (DTBP)
hr).
(100 µg/ml final concentration), for 30 min at room
To differentiate membrane association vs temperature with gentle rocking. Cells were then
membrane integration of Pca1p, membrane washed in the lysis buffer [50 mM Tris-HCl (pH
fractions of prd5Δ, cdc48-3 (cultured at 37 oC), 7.4), 5 mM EDTA, 50 mM protease inhibitor
and doa10Δ cells expressing 3HA epitope-tagged cocktail, and 1 mM PMSF] to quench crosslinking
Pca1p were re-solubilized in phosphate-buffered reaction. Cells were then broken by glass bead
saline (PBS) with and without Na2CO3 or Triton disruption (10 x 1 min on ice). Lysates were
X-100. After incubation at 4 oC for 30 min, collected and fractionated by centrifugation
samples were fractionated by centrifugation (4 oC, (100,000 x g, 30 min). The resulting pellet was
100,000 x g, 30 min). Supernatant (S) was washed twice in ice-cold PBS and re-suspended in
precipitated using Trichloroacetic acid (TCA) and PBS containing Triton X-100 (1 %, v/v) and
denatured in SDS sample buffer. The un-soluble protease inhibitors. Immuno-precipitation was
pellet (N) was denatured in SDS sample buffer. performed using a kit (ProfoundTM c-Myc Tag
Both S and N samples were subjected to Western IP/Co-IP application set, Thermo Scientific)
blot analysis.
according to the manufacturer’s specifications.
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DTT in the SDS sample buffer cleaved the ERAD (34, 35) and its eight predicted
crosslinks.
transmembrane helices, we sought to determine if
Immunoblotting - Yeast cells were broken by ERAD of Pca1p relies on known molecular factors
vortexing (5 x 1 min) with glass beads in the lysis for ERAD of misfolded proteins and how this
buffer (PBS containing 1 mM PMSF, 50 mM polytopic protein is degraded by the proteasome.
protease inhibitor cocktail, 5 mM EDTA, 1% To determine subcellular localization and turnover
Triton X-100). Soluble fraction was obtained by rates of Pca1p, we fused green fluorescent protein
centrifugation (21,000 x g, 15 min). Protein (GFP) or epitope, such as triple hemagglutinin
concentrations were measured using a kit (BCA, (3HA) and two c-myc (2Myc) at the N- or CPierce) according to the manufacturer’s terminus (Fig. 1A). These PCA1 alleles are fully
specifications. Samples were denatured in a functional and display cadmium-dependent ERAD
reducing SDS sample buffer containing (data not shown).
dithiothreitol (DTT, 25 mM) for 15 min at 37 °C
We first determined subcellular distribution of
and then subjected to polyacrylamide gel GFP-Pca1p when proteolytic activities of the
electrophoresis (PAGE). This mild denaturation proteasome are inhibited by MG132 co-culture
condition avoided aggregation of Pca1p which (46) or Cdc48p AAA-ATPase is inactivated (Fig.
contains eight predicted transmembrane helixes. 1B). Cdc48p is a known critical player in
Gels were transferred to nitrocellulose membrane dislodging ERAD substrates from the ER (47). A
and hybridized with primary antibodies against HA strain possessing temperature-sensitive CDC48
epitope (Rockland, 600-401-384), Rpn5p subunit allele (cdc48-3) was used to inactive this essential
of the 19S proteasome (Abnova, PAB 15594), α gene (37) at a restrictive temperature, 37 oC. Cells
and β subunits of 20S proteasome (Abcom, were pre-cultured with cycloheximide to inhibit
ab22673), c-myc epitope (ABM, G019), or new Pca1p synthesis. Pca1p fused with GFP at the
ubiquitin
(Covance,
MMS-257P).
3- N-terminus (GFP-Pca1p) is not detectable in wild
phosphoglycerate kinase (Pgk1p) was detected type (WT) control cells because of rapid turnover
using anti-Pgk1p antibodies (Invitrogen, 459250) as demonstrated previously (35); however, Pca1p
to determine equal loading. Horseradish is highly expressed when the proteasome or
peroxidase-conjugated goat anti-rabbit IgG or Cdc48p is inactivated (Fig. 1B). Co-localization of
sheep anti-mouse IgG (Santa Cruz Biotechnology Pca1p-GFP with Sec63p, an ER resident protein,
Inc) was used as secondary antibodies. Western indicates that Pca1p remains in the ER membrane
Pico Chemiluminescence (Pierce) was used to under the experimental conditions. These results
detect antibody bound proteins.
suggest that ubiquitinylated Pca1p cannot be
Statistical Analysis - Experiment were extracted from the ER membrane without
conducted using minimum two independent clones, proteolytic activities of the proteasome or upon
and representative data was presented. Results inactivation of Cdc48p AAA-type ATPase.
were presented as means ± SD. Student's t-test
We next ascertained cellular levels of Pca1p
determined the statistical differences. P < 0.05 was and its fragments when the proteasome or Cdc48p
considered to be significant.
is inactivated. Pca1p fused with 3HA and 2Myc
(Fig. 1A) was expressed in WT, cdc48-3, and
Results
doa10Δ cells. Western blotting analyses of cell
lysates using anti-HA or c-myc antibodies
Pca1p remains in the membrane when the displayed signals at the locations corresponding to
proteasome is inactivated – Pca1p, a cadmium- full-length Pca1p (the triangle in Fig. 1C). Given
exporting P1B-type ATPase in yeast, is a polytopic that the half-life of Pca1p is less than 5 min (35),
protein (Fig. 1A) that undergoes ERAD in the the majority of remaining Pca1p in wild-type (WT)
absence of cadmium (34). A degron identified cells co-cultured with cycloheximide should be
within amino acids 250 and 350 at the N-terminal ubiquitinylated species. Pca1p fragments below
cytosolic domain (1-557 amino acids, ~61 kDa) full-length Pca1p, including approximately 60, 70,
(Fig. 1A), Doa10p, an E3 ligase, and the 75, and 90 kDa bands, were detected in WT,
proteasome are required for Pca1p turnover (35). cdc48-3, and doa10Δ cells (Fig. 1C, upper panel).
Given cadmium-induced rescue of Pca1p from We previously reported that Pca1p ubiquitinylation
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is absent in doa10Δ cells (34, 35). Therefore, address these concerns, the membrane fractions
fragmentation of Pca1p, observed in doa10Δ cells, were incubated with Na2CO3 (0.2 M, pH 11) (48)
is unlikely a ubiquitinylation-dependent process. to release peripheral membrane proteins to
When probing with anti-myc antibodies, only full supernatant (S) (Fig. 2A). However, all Pca1p
length was detectable and all lower molecular species, including Pca1p fragments that migrate
weight fragments were non-specific as seen by the faster than full-length Pca1p, remain in the nonempty vector control (Fig. 1C, middle panel, lane soluble pellet (N) factions of WT cells co-cultured
1). To determine distribution of Pca1p, total cell with MG132 (Fig. 2A, left panel). Na2CO3
lysates were fractionated by ultra-centrifugation dissociates only a small potion (< 5 %) of full(100,000 x g for 30 min) to supernatant (S) and length and fragmented Pca1p from the membrane
pellet (P) containing soluble proteins and (Fig. 2A, left panel, 3rd lane). Only a small portion
membranes, respectively (Fig. 1D). Western blot of Pca1p detected in the membrane fraction was
analysis detected full-length and higher molecular dissociated by Na2CO3 in Cdc48p-inactive cells
weight Pca1p species at the “P” fraction but not and in doa10Δ cells (Fig. 2A, middle and right
“S” fraction (Fig. 1D). Immuno-precipitation of panels), indicating membrane integration of Pca1p
Pca1p from the “S” and “P” fractions with anti-HA species. Triton X-100 (1 %, v/v) released Pca1p to
antibodies followed by Western blotting using anti- the “S” fraction near completely (Fig. 2A),
HA and -ubiquitin (Ub) antibodies (Fig. 1E) suggesting that most Pca1p and its fragments are
further suggested that most ubiquitinylated Pca1p integrated in the membrane.
species, except a potion of the ~75 kDa fragment,
To confirm Pca1p’s localization in the
reside in the membrane.
membrane rather than aggregated complexes, cell
To rule out any off-target effect of MG132 on lysates were subjected to a sucrose density gradient
proteasome inhibition, we also conducted the fractionation (45) (Fig. 2B). If Pca1p is in
experiments using another proteasome inhibitor, membrane vesicles, it will “float” to the lowbortezomib (40), and a strain expressing a density fractions. WT cells expressing 3HA-tagged
temperature-sensitive allele of CIM3 (cim3-1), Pca1p or Pca1p(degronΔ) lacking first 392 amino
encoding a proteasome subunit (38). Fluorescent acids containing the degron were co-cultured with
confocal microscopy of cells co-cultured with MG132 for 2 hrs. Glass bead-disrupted cells were
bortezomib displayed virtually identical results loaded at the layer of 1.7 M sucrose.
obtained using MG132. However, cells expressing Centrifugation followed by Western blotting
CIM3-1 manifested Pca1p stabilization at the ER at analysis of collected fractions displayed that the
both permissive (23 oC) and restrictive (37 oC) majority of full-length Pca1p and Pca1p(Δ392) are
temperature (data not shown), which was within the membrane-containing low density
confirmed by Western blot analysis (Fig. 1F, 4th fractions, unlike Pgk1p, a soluble protein (Fig. 2B,
lane vs 5th lane). This indicates that Cim3-1p is not 4th panel). Membrane solubilization of cell lysate
fully functional at both 23 and 30 oC. Fractionation with Triton X-100 (1 %, v/v) resulted in coof soluble and membrane proteins followed by fractionation of Pca1p with Pgk1p (Fig. 2B, 3rd
Western blotting of Pca1p also displayed similar panel).
results between bortezomib and MG132 coPca1p species with different degrees of
cultures (Fig. 1G).
ubiquitinylation may exist in the cytosol below
Collectively, the data presented in Fig. 1 detectable limit by Western blot. To address this
suggests that most Pca1p and its fragments, except concern, we assessed the ubiquitinylation status of
for a ~60 kDa fragment, are not dislodged from the Pca1p in the fractions 10, 11 and 12 containing
membrane without the activities of the proteasome soluble proteins. Pca1p was immuno-precipitated
and Cdc48p.
using anti-HA antibodies and then probed with
Pca1p in the pellet fraction exists as antibodies against ubiquitin and HA epitopes (Fig.
membrane-integrated species – We next 2C). The soluble protein fractions contain three
considered the possibilities that Pca1p could be major ubiquitin-conjugated Pca1p fragments (~60,
extracted out of the lipid bilayer but attached to the ~75, and ~90 kDa) (Fig. 2C, 1st panel). It was
membrane or form large cytosolic complexes that further determined that poly-ubiquitinylated fullcould be pulled down to the pellet fraction. To length Pca1p species were not present in the
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soluble fractions since deubiquitinylation by the Fig. 3C, lane 2), and the α and β subunits of 20S
purified catalytic subunit of the de-ubiquintylating proteasome (Fig. 3D) at the membrane. While
enzyme, USP2, did not lead to an enrichment of immuno-precipitation efficiency of Pca1p was over
full-length Pca1p (Fig. 2C, 2nd panel). Anti-HA 90 % (Fig. 3B, 1st panel, lane 2 vs 4), most Rpn5p
antibodies detected primarily a fragment of ~60 (>81%) still remained in the flow-through (Fig.
kDa. Given the predicted N-terminal cytosolic 3B, 2nd panel, lane 2 vs 4). This suggests that
domain (61 kDa + ~3 kDa corresponding to tagged Rpn5p is associated with not only Pca1p but also
3HA epitopes), the ubiquitinylated Pca1p fragment other membrane proteins.
detected in the soluble fraction could be a cleaved
The complex formation between Pca1p and
N-terminal cytosolic domain. However, a portion Rpn5p was dependent on Doa10p and the degron
of the fragment is also detected in the membrane in Pca1p (Fig. 3C). Although expression levels of
fraction as a peptide integrated into membrane Pca1p in doa10Δ cells and Pca1p lacking the
(Figs. 1D, 1G, 2A, and 2B). Therefore, it is likely degron [Pca1p(degronΔ)] were strikingly higher
that the fragment contains one or more trans- than Pca1p levels in wild-type control cells (Fig.
membrane helixes (Fig. 1A) and/or domain(s) 3C, lane 3) (34, 35), immuno-precipitation of
incorporated into the lipid bilayer.
Pca1p and Pca1p(degronΔ) in doa10Δ and WT
Collectively, these results indicate that in the cells, respectively, did not pull down Rpn5p at
absence of proteasomal activities, Pca1p and most detectable levels (Fig. 3C, middle panel). These
of its fragments, except for the ~60 kDa fragment, results confirm the specificity in the complex
are not dislodged from the membrane.
formation between Pca1p and Rpn5p and indicate
Pca1p interacts with the proteasome at the ER that when Pca1p is ubiquitinylated by Doa10p, the
membrane in an E3 ligase and a degron dependent proteasome is recruited while Pca1p resides at the
manner – Given the potential role for the membrane.
proteasome in extraction of Pca1p from the ER, we
Cdc48p is required for the complex formation
next determined if the proteasome forms a between Pca1p and the proteasome – Cdc48p is a
complex with Pca1p at the ER membrane. WT and critical molecular factor for ERAD of Pca1p (Figs.
doa10Δ cells expressing C-terminal two c-myc 1, 2A, 4A) and other proteins (10, 34, 37). ATPase
epitope-tagged wild-type control Pca1p and Pca1p activities of Cdc48p are believed to contribute to
lacking N-terminal 392 amino acids which the retro-translocation of ubiquitinylated luminal
contains a degron [Pca1(degronΔ)] were co- proteins for ERAD (37), and Cdc48p may escort
cultured with MG132 to inactivate the 20S them to the proteasome as demonstrated by a
proteasome. Membrane fractions were isolated as physical interaction between Cdc48p and the
described in Fig. 1D, washed, and solubilized proteasome (37). To determine the role of Cdc48p
[Triton X-100, 1 % (v/v)]. Samples were then in the ERAD of Pca1p in conjunction with the
subjected to immuno-precipitation of Pca1p. the interaction between Pca1p and the proteasome, we
formation of a complex between Pca1p and Rpn5, ascertained if the proteasome forms a complex
a proteasome subunit (49), was visualized by with Pca1p in the cells expressing inactive Cdc48p.
Western blot. However, no detectable association The levels of ubiquitinylated proteins in the cells
was observed without cross-linker co-culture (Fig. expressing non-functional Cdc48p (37 oC culture)
3A, lane 3). This could reflect a transient binding are comparable (1.26 ± 0.62 fold, n=3, p=0.53) to
between Pca1p and the proteasome in the process those of control (23 oC culture) cells (Fig. 4A,
of degradation. To address this concern, we upper panel). Despite higher Pca1p expression in
conducted the experiment using a membrane Cdc48p-defective cells (Fig. 4A, 2nd panel),
permeable thiol–reversible cross-linker, dimethyl immuno-precipitation of Pca1p followed by Rpn5p
3,3'-dithiobispropionimidate
(DTBP).
After detection revealed that formation of a complex
breaking cross-links by denaturing samples in between Pca1p and the proteasome is dramatically
dithiothreitol-containing SDS sample buffer, reduced in cells expressing non-functional Cdc48p
physical interactions of proteasome subunits (46) (Fig. 4B). This result suggests that Cdc48p
with Pca1p were visualized by Western blotting. recognizes ubiquitinylated Pca1p for recruitment to
Indeed, Pca1p was found to form a complex with the proteasome.
Rpn5p, a 19S proteasomal subunit (Fig. 3A, lane 4;
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It was known that Cdc48p also interacts with
other molecular factors involved in ERAD such as
E4 ubiquitin chain extension enzyme (50). The
observed defect of Pca1p ERAD (Fig. 1B) and the
lack of Pca1p interaction with the proteasome (Fig.
4B) in the cells expressing non-functional Cdc48p
may be attributed to a deficiency in recruiting E4
ligase(s) and/or presenting mono-ubiquitinylated
Pca1p for polyubiquitination. To address this, we
determined ubiquitinylation status of Pca1p in
Cdc48p inactive cells. Immunoprecipitation of
Pca1p using anti-HA antibodies followed by
Western blot analysis of Pca1p using anti-ubiquitin
antibodies determined poly-ubiquitinylation of
Pca1p in the cells expressing non-functional
Cdc48p (Fig. 4C). Given that Pca1p levels in cells
expressing nonfunctional Cdc48p are 5-fold higher
relative to those in control cells (Fig. 4A and 4B),
for the experiment presented in Fig. 4C, we loaded
5-fold
higher immuno-precipitated
sample
obtained from cells cultured at 23 oC. Our data
displayed that the cells expressing non-functional
Cdc48p accumulate poly-ubiquitinylated Pca1p
comparable to control cells (Fig. 4C). Therefore,
the higher Pca1p expression (Fig. 4A, 2nd panel)
and the reduced association of Pca1p with the
proteasome (Fig. 4B) in Cdc48p-inactive cells are
unlikely attributed to a defect in polyubiquitinylation of Pca1p.
Ufd2p, an E4 Ubiquitin Extension Enzyme for
Pca1p, and poly-ubiquitinylation of Pca1p did not
affect complex formation between Pca1p and the
proteasome – Following ubiquitinylation by E3
ligase(s), E4 ubiquitin chain extension enzymes,
such as Ufd2p and Hul5p in yeast, have been
implicated in the degradation of several ERAD
substrates (10, 32, 50, 51). Ufd2p interacts with
Cdc48p and Rad23p in the process of substrate
delivery to the proteasome (28). It is intriguing that
Ufd2p regulates turnover of only a subset of
Doa10p substrates (33), and Hul5p has been found
to be associated with the 19S proteasome (32, 52,
53). We determined the half-life (T1/2), polyubiquitinylation of Pca1p, and formation of a
complex between Pca1p and the proteasome in
ufd2Δ and hul5Δ strains. Cycloheximide chase of
Pca1p revealed no significant difference in Pca1p
degradation in WT and hul5Δ cells; however,
UFD2 deletion dramatically extended T1/2 of Pca1p
(Figs. 5A and 5B). This result suggests that Ufd2p
is required for efficient turnover of Pca1p.

Immuno-precipitation of Pca1p followed by
immunoblotting using anti-ubiquitin antibodies
supported that Ufd2p is the major E4 enzyme of
Pca1p (Fig. 5C). In the ufd2Δ cells, most Pca1p
species were detected at the membrane
fractionation but not at the soluble fraction (Fig.
5D) indicating that in the ufd2Δ cells, the majority
of Pca1p remains in the membrane.
As Ufd2p is required for efficient degradation
of Pca1p (Fig. 5B), we next sought to determine if
poly-ubiquitinylation by Ufd2p is necessary for the
interaction of Pca1p with the proteasome. In vivo
cross-linking
and
co-immunoprecipitation
followed by Western blot analysis showed that
Pca1p is still able to interact with the proteasome
in the absence of Ufd2p (Fig. 5E). This indicates
that Ufd2p-dependent ubiquitin chain extension
(Fig. 5C) is not critical for formation of a complex
between Pca1p and the proteasome. This result
also further confirmed that the reduced interaction
of Pca1p with the proteasome in cells expressing
nonfunctional Cdc48p (Figs. 4B and 4C) is not
relevant to poly-ubiquitinylation status of Pca1p.
Proteasome dependent extraction of ERAD
substrates is specific for polytopic proteins – We
next determined if other poly-topic membrane
proteins undergoing ERAD manifest an interaction
with the proteasome at the membrane as observed
for Pca1p. Ste6*p is a mutated form of the alpha
factor transporter Ste6p in yeast (54), which causes
a premature stop codon and a change in Nglycosylation. Ste6*p is also targeted for
degradation via Doa10p, Cdc48p, and proteasome
dependent pathway (10, 54, 55). Subcellular
fractionation and flotation sucrose gradient
fractionation showed that Ste6*p remained in the
membrane fraction under proteasome inhibition
conditions (data not shown) as observed for Pca1p.
The same experiment described in Fig. 3A showed
that Ste6*p pulled down a proteasome subunit
Rpn5p in a Doa10p-dependendent manner (Fig.
6A). Therefore, Ste6*p also interacts with the
proteasome at the ER membrane when it is
ubiquitinylated by Doa10p.
The expression of Hmg2p, an ER-resident
membrane enzyme required for cholesterol
synthesis, is controlled through the ERAD-M
pathway. When the proteasome is inactivated by
MG132 co-culture, Hmg2p also forms a complex
with the proteasome at the membrane and not in
the cytosol (Fig. 6B). Therefore, as observed for
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Pca1p and Ste6*p, inhibition of proteolytic in ERAD (60, 61), although the mechanistic details
function of the proteasome prevents Hmg2p remain to be defined.
Despite experimental
release from the ER membrane.
evidence arguing a non-essential role of Cdc48p in
Vacuolar carboxypeptidase Y (Cpy1p) the ERAD process (62), our study confirmed that
containing a G255R mutation (Cpy1*p) is Cdc48p is a significant player for ERAD of Pca1p
degraded through the ERAD-C pathway (13, 56- by promoting its binding to the proteasome. In
59). We have employed Cpy1*p as an example of cells expressing inactive Cdc48p, the complex
an ER luminal protein to elaborate the hypothesis formation between the proteasome and Pca1p and
that soluble ERAD substrates may be retro- Pca1p degradation is impaired. This result is
translocated prior to being targeted to the consistent to a previous report displaying a
proteasome. When WT yeast cells expressing c- cooperation between Cdc48p and the proteasome
myc epitope tagged Cpy1*p were co-cultured with in turnover of Insig-1p, an ERAD-M substrate
MG132, a proteasome inhibitor, Cpy1*p was (63). Several lines of evidence support that Cdc48p
detected as full-length and poly-ubiquitinylated and its cofactors, Ufd1p and Npl4p, are recruited to
forms in the soluble (S) fraction (Fig. 6C). Rpn5p, the ER via Ubx2p to disassemble ubiquitina subunit of 19S proteasome, was co- conjugated substrates from the membrane and for
immunoprecipitated with Cpy1*p in soluble the delivery of those to the proteasome (60, 61).
fraction (Fig. 6C, 2nd panel) indicating that Therefore, it is likely that Cdc48p facilitates the
Cpy1*p forms a complex with the proteasome in interaction between ubiquitinylated Pca1p and the
the cytosol. However, Cpy1*p in the cells lacking proteasome.
Hrd1p E3 ligase targeting Cpy1*p for ERAD
Distinct from the ERAD-L pathway dealing
remains at the pellet fraction along with Kar2p, an with soluble substrates, a concern in ERAD of
ER luminal protein (Fig. 6D); therefore, detection integral membrane proteins (ERAD-M and -C
of Cpy1*p in soluble fraction (Fig. 6C) is a pathways) would be the extraction of proteins from
consequence of ERAD progress of Cpy1*p rather the lipid bilayer and solubilization at the cytosol
than its leaking from the ER during sample (10, 64). While several potential mechanisms have
preparation followed by interaction with the been proposed (3, 10, 32), the results reported
proteasome. These results suggest that Cpy1*p previously were not consistent with each other. An
ubiquitinylated by Hrd1p is retro-translocated to in vitro reconstitution assay found that prior to
the cytosol without proteolytic activities of the degradation, Ste6*p, a well-characterized ERAD-C
proteasome. This is distinct from other examined substrate, is dislodged from the membrane (10);
polytopic proteins, Pca1p, Ste6*p, and Hmg2p.
however, it is worth pointing out that only a small
fraction of Ste6*p was released from the
Discussion
membrane under the experimental conditions.
Secondly, an in vitro ERAD assay of CFTR
ERAD involves retro-translocation of ER displayed relatively minor effects of proteasome
luminal proteins and dislodging of membrane inactivation on extraction and release of its
proteins. Our data suggests that polytopic ERAD degradation intermediates from the ER membrane
substrates undergo proteasomal degradation at the (65). Our study was conducted in cells, and most
ER membrane via recruiting the proteasome rather ubiquitinylated Pca1p and its fragments remained
than being extracted to the cytosol prior to delivery in the membrane and formed a complex with the
to the proteasome. This is distinct from ERAD of proteasome. This finding was confirmed with two
Cpy1*p, a soluble protein in the lumen of the ER. other polytopic proteins. Therefore, our data
The coupling of dislodging and destruction of supports the hypothesis that dislodging of
membrane proteins would be advantageous for membrane proteins does not occur prior to their
cells by minimizing the energy cost associated delivery to the proteasome.
with dealing hydrophobic proteins in the cytosol.
Detection of the complex containing Pca1p
These results shed new light on this vital but under and subunits of 19S and 20S proteasome from the
characterized process.
membrane fractions is dependent on Doa10p, the
Cdc48p (p97/VCP in higher eukaryotes), a major E3 ubiquitin ligase of Pca1p. This suggests
hexameric AAA-type ATPase, plays diverse roles that ubiquitinylated Pca1p attracts the proteasome
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while residing in the ER membrane. The regulatory particle of yeast, is involved in ERAD
proteasomes are localized mainly in the nucleus of reporter substrates (e.g., CTL* and Sec61-2L)
and cytosol as free or nuclear envelope and ER (32) and proteasome-dependent degradation of
network-attached forms (66-68). The clustering of cytosolic proteins that are damaged under heat
the proteasomes on the ER membrane is stress (52). However, knockout of UFD2 gene
particularly high in the yeast S. cerevisiae (> 80 % encoding another E4 ligase did not affect the heattotal proteasome) relative to mammals (< 20 %) induced ubiquitylation (52). Our study on the
(67). The proteasome might be associated with the turnover rate of Pca1p in hul5Δ and ufd2Δ strains
ER via physical interaction with ER membrane showed that the Ufd2p but not Hul5p is involved in
protein(s), which is reminiscent of Cue1 and ERAD of Pca1p, confirming target specificity of
Ubx2p recruiting Ubc6p/7p and Cdc48p to the ER E4 ligases. Nevertheless, it’s worth noting that the
membrane, respectively (71-73). This may allow relative stability of Pca1p in ufd2Δ strain was still
for rapid recognition of ERAD substrates by the significantly lower than that of the doa10Δ strain
proteasome. Sts1p is critical for enriching the (T1/2 = 30 min vs > 2 hrs), which suggests that
proteasome at the nuclear envelope (70); however, poly-ubiquitinylation is not essential for ERAD but
the counterpart at the ER membrane remains to be enhances the efficiency. One might argue that,
identified. Alternatively, the enrichment of the given three other E4 ligases in addition to Hul5p
proteasome at the ER membrane might reflect the and Ufd2p in the genome of the yeast S. cerevisiae
complexes between the proteasome and proteins (76), there may be some redundancy. However, we
undergoing ERAD. High demand of ERAD might disproved this by showing near absence of polycontrol the distribution of the proteasomes for an ubiquitinylated Pca1p in ufd2Δ cells. It is also
efficient completion of the task. The 26S, 20S, and interesting to note that, although Pca1p turnover is
19S proteasomal particles are known to exist in a slow in ufd2Δ cells and a drastic reduction of polydynamic equilibrium (68). The assembly, subunit ubiquitinylation of Pca1p in the cells, Ufd2p
composition, post-translational modifications of deficiency does not affect the formation of a
amino acid residues, and interaction of the complex between Pca1p and the proteasome.
proteasome with regulators(s) if any, could be These results indicate that poly-ubiquitinylation of
changed in response to cellular cues and stresses Pca1p is not a critical determinant of initial
(66). It would be interesting to examine if ER interaction with the proteasome but rather
stresses would lead to an enrichment of the promotes efficient processing of substrates by the
proteasomes to the ER membrane. This could be proteasome.
better accessed in mammals displaying relatively
This study reflects a comprehensive in vivo
minor steady state ER localization of the study determining how polytopic proteins are
proteasome (74, 75).
targeted to the ERAD pathway in yeast. The
The significance of polyubiqitinylation of recruitment of the proteasome to ubiquitinylated
membrane proteins in ERAD remains an intriguing proteins while they reside in the membrane could
question. The regulatory particles of the be a conserved mechanism in ERAD of higher
proteasome contain several functional components, eukaryotes. It would be also interesting to define
including AAA-Type ATPase, E4 ubiquitin whether the proteasome-dependent destruction of
ligase(s), and de-ubiquitinylation enzyme(s). membrane proteins in other organelles occurs in a
Hul5p, an E4 enzyme associated with the similar manner.
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Figure Legends
FIGURE 1. Localization of Pca1p at the membrane of the cells in which the proteasome or Cdc48p
is inactivated. A, A schematic depiction of Pca1p. The black squares indicate eight trans-membrane
helixes. Green fluorescent protein (GFP) or triple HA epitope (3HA) is fused at the N-terminus (filled
oval). Two c-myc epitope (2Myc) is fused at the C-terminus (empty oval). The unfilled square indicates
the amino acid 250-350 region containing a degron. B, Subcellular distribution of Pca1p determined by
fluorescent microscopy. Expression plasmids of GFP-fused Pca1p and red fluorescent protein (RFP)fused Sec63p, an ER-resident protein, were co-expressed in a control strain lacking PDR5 (WT) and a
strain containing a temperature-sensitive allele of CDC48 (cdc48-3). Mid-log phase cells were cultured
with and without MG132 for 2 hrs. Cycloheximide was added to the media 1 hr before collecting cells.
The cdc48-3 cells cultured at 23 oC were shifted to 37 oC for 30 min. Subcellular distribution of Pca1pGFP was visualized by confocal fluorescent microscopy. C, Detection of Pca1p and its fragments by
immuno-blotting. Pca1p fused with 3HA and 2Myc was expressed in a WT, a strain expressing cdc48-3
allele, and a doa10Δ strain. WT and cdc48-3 cells were pre-cultured with MG132 for 2 hrs and at 37 oC
for 30 min, respectively. Total cell extracts prepared by glass bead disruption and Triton X-100 (1 %)
solubilization were subjected to Western blot using anti-HA and -myc antibodies. The blots were also
probed with anti-Pgk1p antibodies to determine equal loading. D, Determination of subcellular
distribution of Pca1p. Lysates of the cells that were cultured as described in C were prepared by glass
bead disruption followed by removing un-broken cells (300 x g for 10 min centrifugation). The samples
were separated to soluble (S) and pellet (P) fractions by centrifugation (100,000 x g for 30 min). The S
and P fractions were solubilized (1 % Triton X-100) and subjected to Western blot analysis using AntiHA antibodies. E, Detection of majority of ubiquitinylated Pca1p at the P fraction. Pca1p in the S and P
fractions obtained from WT cells as described above was immuno-precipitated using anti-HA antibodies.
Expression levels and ubiquitinylation status of Pca1p were determined by Western blot using anti-HA
and -ubiquitin (Ub) antibodies, respectively. F and G, The experiments presented in C and D were
conducted using bortezomib, a proteasome inhibitor, and a strain carrying a temperature-sensitive cim3-1
allele. The triangle (C - G), asterisks (C, F, G), and arrows (C, F) indicate the location of full-length nonubiquitinylated Pca1p, non-specific bands detected by anti-myc (C) or anti-HA (F) antibodies, and a
Pca1p fragment dominant in proteasome-inactive WT cells relative to other cells, respectively. Each
experiment was conducted three or more times using different clones, and representative data is
presented.
FIGURE 2. Detection of fragmented or ubiquitinylated Pca1p by subcellular fractionation. A,
Majority of Pca1p and its fragments are embedded in the membrane. Pca1p fused with triple HA at the Nterminus was expressed in a control strain lacking PDR5 (WT), a strain expressing a cdc48-3 temperature
sensitive allele, and a doa10Δ strain. WT and cdc48-3 cells were cultured with MG132 (20 µM, 2 hrs)
and at 37oC (30 min), respectively. Membrane fractions obtained by centrifugation (100,000 x g, 30 min)
of total cell lysate were re-suspended in phosphate-buffered saline (PBS) with and without Na2CO3 (0.2
M, pH 11) or Triton X-100 (1 %). The samples were incubated for 30 min on ice and then centrifuged at
100,000 × g for 30 min. The supernatant (S) was precipitated in trichloroacetic acid (10 %) and washed
twice with acetone. The nonsoluble pellet (N) was re-suspended in PBS containing detergent (1 % Triton
X-100). Samples were denatured in SDS sample buffer (37 oC, 15 min) and analyzed by Western blot
using anti-HA antibodies. B, Fractionation of Pca1p by flotation sucrose gradient. WT cells expressing
3HA-tagged Pca1p or Pca1p(degronΔ) lacking first 392 amino acids containing a degron were cocultured with MG132 for 2 hrs. Cycloheximide was added to the media 1 hr before collecting cells. Total
cell lysates were prepared by glass bead disruption followed by centrifugation (300 x g, 10 min) to
remove unbroken cells. Samples were loaded at the layer of 1.7 M sucrose density at a 0.25 to 2.3M
gradient from the top to bottom. After centrifugation (100,000 x g, 5 hrs), the collected fractions were
subjected to Western blotting. An aliquot was incubated with Triton X-100 (1 %) on ice for 30 min before
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the fractionation to extract Pca1p out of the membrane. Obtained fractions were subjected to Western blot
analyses of Pca1p and Pca1p(degronΔ) using anti-HA antibodies. Pgk1p was detected as a marker of
fractions containing soluble proteins. C, Distribution of full-length, ubiquitinylated, and fragmented
Pca1p species. Fractions obtained as described in B were subjected to Western blot analysis of Pca1p with
and without treatment of deubiquitinylation enzyme. Fractions 10, 11 and 12 containing cytosolic proteins
were pooled, deubiquitinylated (De-Ub), and then solubilized by detergent (1 % Triton X-100). Pca1p
was immuno-precipitated using anti-HA antibodies. The samples were subjected to Western blotting
using anti-ubiquitin (Ub) and -HA antibodies. The triangle indicates the location where full-length nonubiquitinylated Pca1p migrates. Results were confirmed by three or more repeats, and representative data
is presented.
FIGURE 3. Pca1p forms a complex with the proteasome at the membrane in a Doa10p dependent
manner. Pca1p, Pca1p(degronΔ) deleting first 392 amino acids, and control empty vector were expressed
in WT and doa10Δ strains. Two c-myc epitopes were tagged at the C-terminus of Pca1p. Cells were
cultured with and without a cell permeable and reversible cross-linker (DTBP, 100 µg/ml) and MG132
(20 µM) for 2 hrs. Cell lysates were obtained by Triton X-100 (1 %) solubilization of membrane fraction.
The samples were subjected to immunoprecipitation using anti-myc antibodies. Co-immunoprecipitation
of Pca1p with Rpn5p, a subunit of 19S regulatory particle (A, C), and α and β subunits of 20S catalytic
core (D) was determined by Western blotting. B, Pcalp and Rpn5 levels in the input (cell lysate) and flowthrough of Pca1p immune-precipitation (IP flow-through) were compared by Western blotting. Each
experiment was conducted twice using two independent clones, and representative data is presented.
FIGURE 4. Cdc48p plays a role in Pca1p’s complex formation with the proteasome but not its polyubiquitinylation. A, No significant change of protein poly-ubiquitinylation in cells expressing nonfunctional Ccd48p. Pca1p tagged with triple HA epitope was expressed in a strain carrying a temperaturesensitive cdc48-3. The cells at mid-log phase were cultured at a permissive temperature (23 oC), or shifted
to a restrictive temperature (37 oC), for 30 min with a cell permeable and reversible cross-linker (DTBP,
100 µg/ml) and MG132 (20 µM), a proteasome inhibitor, for 2 hrs. Membrane fractions were solubilized
with Triton X-100 (1 %). Expression levels of Pca1p and Rpn5p and the overall ubiquitinylation status
were determined by Western blot. B, Cdc48p-dependent physical association between Pca1p and Rpn5p,
a subunit of 19S regulatory particle, was determined by co-immunoprecipitation. Triton X-100 (1 %)
solubilized membrane fraction was used for immune-precipitation of Pca1p using anti-HA antibodies. Coimmunoprecipitation of Rpn5p, a subunit of 19S regulatory particle was detected by Western blot. C,
Poly-ubiquitinylation of Pca1p as a functional of Cdc48p activities. To determine ubiquitinylation status
of Pca1p, the samples obtained as described in B were subjected to Western blot using anti-ubiquitin
antibodies. To compare relative ubiquitinylation of Pca1p, five-fold amount of immune-precipitated
Pca1p from cells cultured at 23 oC relative to those at 37 oC was loaded. Each data was confirmed by
triplicate experiments.
FIGURE 5. Formation of a complex between Pca1p and the proteasome is independent of polyubiquitinylation of Pca1p. A, Significant reduction of turnover rate of Pca1p in UFD2 gene knockout
(ufd2Δ) cells. Pca1p tagged with two c-myc epitope at the C-terminus was expressed in WT, ufd2Δ, and
hul5Δ strains. Cycloheximide (CHX) chase and Western blot determined Pca1p levels. Protein extracts
were prepared by glass bead disruption and detergent (1 % Triton X-100) solubilization. Pgk1p was
probed to determine equal loading. B, Pca1p levels presented in A were quantitated (n=4). Pca1p levels
relative to those at time 0 are presented. Asterisk indicates p<0.01. C, Defect in poly-ubiquitinylation of
Pca1p in a ufd2Δ strain. Pca1p tagged c-myc epitope was expressed in a ufd2Δ strain. Total cell lysates
(T) were obtained with and without co-culture with MG132 (20 µM, 2 hrs). Samples were subjected to
separation to soluble (S) and pellet (P) fractions by centrifugation (100,000 x g for 30 min). After
solubilization with Triton-X 100 (1 %), S and P fractions were subjected to immune-precipitation using
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anti-myc antibodies followed by Western blotting using anti-ubiquitin (Ub) and -myc antibodies to detect
Pca1p. D, Distribution of Pca1p species in the S and P fractions in ufd2Δ cells. Total cell lysates (T) and
soluble (S) and pellet (P) fractions described in C were subjected to Western blot using anti-myc and Pgk1p antibodies. E, Formation of a complex between Pca1p and Rpn5p, a subunit of the 19S
proteasome. After co-culturing the cells with a permeable and reversible cross-linker (DTBP, 100 µg/ml)
and MG132, an inhibitor of proteasomal proteolytic activities, cell lysates were obtained by glass bead
disruption and detergent solubilization. The samples were subjected to immunoprecipitation using antimyc antibodies. Rpn5p in the samples was detected by Western blotting using anti-Rpn5p antibodies. The
triangle (C and D) indicates the location where full-length Pca1p migrates. Experiment (B - D) was
conducted twice using two independent clones, and representative data is presented.
FIGURE 6. Ste6*p, Hmg2p, and Cpy1*p form a complex with the proteasome at the membrane.
Ste6*p, Hmg2p, or Cpy1*p tagged with either HA or c-myc epitope was expressed in WT control (A-C)
doa10Δ (A) and hrd1Δ (D) cells. Cells were co-cultured with MG132 (20 µM, 2 hrs), an inhibitor of
proteasomal proteolytic activities, and a cell permeable reversible cross-linker (DTBP, 100 µg/ml, 30
min). Total cell lysates (T) were prepared by glass bead disruption. Samples were subjected to separation
of soluble (S) and membrane (P) fractions by centrifugation (100,000 x g, 30 min). Protein extracts were
obtained by solubilizing samples with detergent (1 % Triton X-100). A, The membrane (P) fractions were
used to determine an interaction of Ste6*p with the proteasome. HA-Ste6*p were subjected to anti-HA
immunoprecipitation followed by Western using anti-HA and anti-Rpn5 antibodies. B and C, Lysates of
WT cells expressing Hmg2p-myc or Cpy1*p-myc were subjected to fractionation (S and P) followed by
detergent solubilization. Anti-myc immunoprecipitation and Western blotting using anti-Rpn5p and -myc
antibodies determined their physical interaction. Ubiquitinylation status was determined by probing the
blots with anti-ubiquitin (Ub) antibodies (C, middle panel). D, Cpy1*p expressed in total cell lysate (T)
and S and P fractions of hrd1Δ cells was detected by Western blot using anti-myc antibodies. The blots
were also probed with antibodies against Kar2p and Pgk1p, an ER-resident protein and cytosolic protein,
respectively. Representative figures of two or more independent experiments are presented.
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